Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of AVASTAN 40 mg vs LIPITOR 40 mg (atorvastatin) in Healthy Subjects Under Fasting Conditions
TCTR20221103007Phase 1Unknown
- Sponsor
- Government Pharmaceutical Organization
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of atorvastatin in hypercholesterolemia, dyslipidemia and hyperlipidemia (2 arms), sponsored by Government Pharmaceutical Organization. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemiadyslipidemiahyperlipidemia
Beyond the preview
Go deeper on TCTR20221103007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221103007.